Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Insider Analysis From L.E.K. Consulting On The Private Health Insurance Market In China: Business As Usual Or Breakthrough Imminent?

This article was originally published in PharmAsia News

Executive Summary

In the midst of China’s massive healthcare reforms, including focus on expanding health insurance coverage, one area has not received much attention from policy makers and market participants until recently – the private health insurance market.

You may also be interested in...

China's Pilot DRG Reimbursement Systems Indicate Substantial Changes To Hospital Prescription Habits

SHANGHAI - China is experimenting with pilot reimbursement programs that rely on diagnosis related groups (DRG) in cities across the country, looking for ways to reduce medical expenses

China Signals Need For Private Investment To Support Its Healthcare Reforms; Private Insurance Options Likely To Widen

SHANGHAI - China recently lifted a ban on foreign investment in medical institutes to support its $124 billion healthcare reforms and the establishment of wholly foreign-owned hospitals and clinics. The move by the Chinese government is being read as a signal that China may open more of the country's healthcare industry to foreign investment

Insider Analysis From L.E.K Consulting On Expanding In China’s Medtech Market (Part 3 of 3)

Already the fourth largest medtech market in the world, China’s $17 billion medical device industry is expected to more than double in size in the next five years, paving the way for incredible opportunities for growth. Identifying where the opportunities lie, navigating the tendering process and determining the right sales and distribution models are essential for multinational device makers.


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts